The partnership between TriMetis Life Sciences and ISENET represents a significant leap forward in pathology research. By combining TriMetis' Computer-Assisted Pathology (TCAP) AI with ISENET's Galileo TMatic, we're introducing a revolutionary automated tissue coring system for TMA construction and tissue isolation for genomic analyses. This cutting-edge technology eliminates the need for manual identification of regions of interest by pathologists, saving valuable time and resources. TCAP's AI capabilities rapidly identify tumor content based on cellularity, precisely locating areas for coring, while Galileo's automated tissue coring technology extracts tissues with minimal intervention. Together, these technologies streamline the research process, enabling researchers to quickly identify and extract areas with the desired cells for further analysis. This partnership is poised to transform pathology research, ultimately accelerating research and changing healthcare. Contact us to learn more about how we're paving the new path forward in innovation and technological advancement in pathology.